Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-062103
Filing Date
2012-12-04
Accepted
2012-12-04 12:04:34
Documents
1
Period of Report
2012-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd362193.html 4  
1 FORM 4 rrd362193.xml 4 5392
  Complete submission text file 0001181431-12-062103.txt   6704
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Issuer) CIK: 0001107332 (see all company filings)

EIN.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 2ND AVENUE SEATTLE WA 98101
Business Address
Rocco Lindsay (Reporting) CIK: 0001562381 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35546 | Film No.: 121239712